Evaxion Biotech AS (EVAX)
1.49
+0.12
(+8.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
-0.07
(-4.70%)
After-Hours: 20:00
Evaxion Biotech Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -0.077M |
| March 31, 2022 | -0.159M |
| December 31, 2021 | -0.177M |
| September 30, 2021 | -0.331M |
| June 30, 2021 | -0.495M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.327M |
| December 31, 2020 | -0.262M |
| September 30, 2020 | -0.005M |
| June 30, 2020 | -0.045M |
| March 31, 2020 | -0.081M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.495M
Minimum
Jun 2021
-0.005M
Maximum
Sep 2020
-0.1959M
Average
-0.168M
Median
Cash from Investing (Quarterly) Benchmarks
| Ascendis Pharma AS | -- |
| DBV Technologies SA | -0.109M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -361.0% |